A recent study has discovered a high concentration of biomarkers associated with Alzheimer's disease in the blood, providing potential for early detection and treatment.
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Oct 27, 2023
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Alzheimer's Biomarkers Blood Study Early Detection Treatment
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cyclists are more caring over range of issues affecting their communities than drivers, study findsStudy: Cyclists more caring than drivers on community issues
Read more »
Lack of Sleep Linked to Increased Risk of Depression, Study FindsResearch suggests that consistently sleeping less than five hours a night could increase the risk of depression. A study led by UCL researchers found that people with a genetic predisposition to short sleep were more likely to develop depressive symptoms over time. However, the link between sleep and depression was not exclusive to those with a genetic association. The study highlights the complex relationship between sleep duration and mental health.
Read more »
Current jargon on antibiotic resistance fails to stick or scare, study findsResearchers find that current terminology related to antimicrobial resistance (AMR) fails to effectively communicate the risks to the public. The study reveals that terms like 'AMR' and 'antimicrobial resistance' are poorly remembered and do not evoke sufficient risk perception, highlighting the need for improved public health messaging.
Read more »
SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a yearResearchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.
Read more »
New study highlights risks of anti-ERBB2 cancer drugs during pregnancyStudy finds that anti-ERBB2 inhibitors used in breast cancer treatment pose significant risks to pregnancy and fetal health, including higher likelihoods of congenital defects and intrauterine growth restriction.
Read more »